AlzChem Group AG (ACT) - Total Liabilities
Based on the latest financial reports, AlzChem Group AG (ACT) has total liabilities worth €378.41 Million EUR (≈ $442.41 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of AlzChem Group AG to track the company's year-over-year net asset growth rate.
AlzChem Group AG - Total Liabilities Trend (2008–2025)
This chart illustrates how AlzChem Group AG's total liabilities have evolved over time, based on quarterly financial data. See AlzChem Group AG (ACT) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
AlzChem Group AG Competitors by Total Liabilities
The table below lists competitors of AlzChem Group AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Acuren Corporation
NYSE:TIC
|
USA | $2.20 Billion |
|
Believe SAS
PA:BLV
|
France | €811.38 Million |
|
Vericel Corp Ord
NASDAQ:VCEL
|
USA | $133.33 Million |
|
FirstSun Capital Bancorp Common Stock
NASDAQ:FSUN
|
USA | $7.39 Billion |
|
Modern Times Group Mtg AB
ST:MTG-B
|
Sweden | Skr8.67 Billion |
|
Wangfujing
SHG:600859
|
China | CN¥19.44 Billion |
|
Sinosoft Co Ltd
SHG:603927
|
China | CN¥4.55 Billion |
|
Jiangsu Ruitai New Energy Materials Co. Ltd.
SHE:301238
|
China | CN¥1.96 Billion |
Liability Composition Analysis (2008–2025)
This chart breaks down AlzChem Group AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see AlzChem Group AG stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.26 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.37 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how AlzChem Group AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for AlzChem Group AG (2008–2025)
The table below shows the annual total liabilities of AlzChem Group AG from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €359.45 Million ≈ $420.23 Million |
+30.07% |
| 2024-12-31 | €276.36 Million ≈ $323.09 Million |
+5.84% |
| 2023-12-31 | €261.12 Million ≈ $305.27 Million |
-5.70% |
| 2022-12-31 | €276.91 Million ≈ $323.74 Million |
-3.88% |
| 2021-12-31 | €288.10 Million ≈ $336.82 Million |
+0.86% |
| 2020-12-31 | €285.64 Million ≈ $333.94 Million |
+1.57% |
| 2019-12-31 | €281.23 Million ≈ $328.79 Million |
+14.71% |
| 2018-12-31 | €245.16 Million ≈ $286.62 Million |
+10.29% |
| 2017-12-31 | €222.29 Million ≈ $259.88 Million |
+345125.12% |
| 2016-12-31 | €64.39K ≈ $75.28K |
+74.02% |
| 2015-12-31 | €37.00K ≈ $43.26K |
+46.68% |
| 2014-12-31 | €25.23K ≈ $29.49K |
+115.19% |
| 2013-12-31 | €11.72K ≈ $13.70K |
+123.48% |
| 2012-12-31 | €5.25K ≈ $6.13K |
+9.27% |
| 2011-12-31 | €4.80K ≈ $5.61K |
-87.39% |
| 2010-12-31 | €38.08K ≈ $44.52K |
+1.54% |
| 2009-12-31 | €37.50K ≈ $43.84K |
+15.38% |
| 2008-12-31 | €32.50K ≈ $38.00K |
-- |
About AlzChem Group AG
AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, f… Read more